Back
Home
Search
Glioblastoma
Newly Diagnosed
1
Recurrent
1
Protocols
EAF223
OPEN TO ACCRUAL
Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)
UW22152
OPEN TO ACCRUAL
A Dose Finding Study of (177Lu)Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Stan
loading